Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2025-09-18 00:00:00 ET · period of report 2025-09-18 · accession 0001231589-25-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-09-18 | 2025-09-18 | UTHR | MAHON PAUL A | EVP, GC | S - Sale+OE | $406.17 | -11.0K | 38.0K | -22% | -$4.47M |
| DT | 2025-09-18 | 2025-09-18 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $135.42 | +11.0K | 47.8K | +30% | +$1.49M |
| DT | 2025-09-18 | 2025-09-18 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $0.00 | -11.0K | 55.0K | -17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-18 | S | D | 2,973 | $405.45 | 43,308 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $404.90 to $405.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2025-09-18 | S | D | 3,222 | $406.39 | 40,086 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $405.90 to $406.885. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2025-09-18 | S | D | 1,200 | $408.11 | 36,781 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $407.985 to $408.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2025-09-18 | M | A | 11,000 | $135.42 | 47,781 | D | — | — | |
| 5 | Common | Common Stock | 2025-09-18 | S | D | 1,100 | $404.33 | 46,281 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $403.76 to $404.70. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 6 | Common | Common Stock | 2025-09-18 | S | D | 400 | $402.50 | 47,381 | D | — | — | |
| 7 | Common | Common Stock | 2025-09-18 | S | D | 2,105 | $407.42 | 37,981 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $406.91 to $407.895. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 8 | Derivative | Stock Option | 2025-09-18 | M | D | 11,000 | $0.00 | 55,000 | D | $135.42 · 2023-03-15 to 2027-03-15 | 11,000 Common Stock |